Cardiomyocytes produced with success

One of the possibilities for the clinical-experimental use of iPS cells is to develop human-like tissues -organoids- for use in basic research or in preclinical therapeutic studies. Now, using iPS cells obtained from primates, a team from Colombia University in New York has produced cardiomyocytes (heart muscle cells capable of contracting spontaneously and individually) with >85% purity in only 10 days in the presence of a biochemical medium, in very defined conditions. 85% The cells obtained showed normal cardiac markers and electromechanical characteristics. They say “Our approach provides a powerful tool for the generation of NHP iPSC-derived cardiomyocytes amenable to utilization in basic research and preclinical studies, including in vivo tissue regeneration models and drug screening (see HERE article).

Image Discovery Medicine
close

Subscribe

Subscribe to our newsletter:

We don’t spam! Read our privacy policy for more info.